Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age-a sibling control study

2010 ◽  
Vol 77 (5) ◽  
pp. 492-498 ◽  
Author(s):  
JJ McGill ◽  
AC Inwood ◽  
DJ Coman ◽  
ML Lipke ◽  
D de Lore ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Enzyme Replacement ◽  
Sibling Control ◽  
Mucopolysaccharidosis Vi ◽  
Control Study

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)

2004 ◽  
Vol 144 (5) ◽  
pp. 574-580 ◽  
Author(s):  
Paul Harmatz ◽  
Chester B Whitley ◽  
Lewis Waber ◽  
Ray Pais ◽  
Robert Steiner ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Enzyme Replacement ◽  
Mucopolysaccharidosis Vi

Enzyme replacement therapy for mucopolysaccharidosis VI—experience in Taiwan

2010 ◽  
Vol 33 (S3) ◽  
pp. 421-427 ◽  
Author(s):  
Hsiang-Yu Lin ◽  
Ming-Ren Chen ◽  
Chih-Kuang Chuang ◽  
Chih-Ping Chen ◽  
Dar-Shong Lin ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Enzyme Replacement ◽  
Mucopolysaccharidosis Vi

Genotypic-phenotypic features and enzyme replacement therapy outcome in patients with mucopolysaccharidosis VI from Turkey

2017 ◽  
Vol 173 (11) ◽  
pp. 2954-2967 ◽  
Author(s):  
Mustafa Kılıç ◽  
Ali Dursun ◽  
Turgay Coşkun ◽  
Ayşegül Tokatlı ◽  
Rıza K. Özgül ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Therapy Outcome ◽  
Enzyme Replacement ◽  
Mucopolysaccharidosis Vi ◽  
Phenotypic Features

scholarly journals Erratum to: Enzyme replacement therapy for mucopolysaccharidosis VI—experience in Taiwan

2010 ◽  
Vol 36 (4) ◽  
pp. 705-705 ◽  
Author(s):  
Hsiang-Yu Lin ◽  
Ming-Ren Chen ◽  
Chih-Kuang Chuang ◽  
Chih-Ping Chen ◽  
Dar-Shong Lin ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Enzyme Replacement ◽  
Mucopolysaccharidosis Vi

Musculoskeletal manifestations of mucopolysaccharidosis type VI and effects of enzyme replacement therapy

Open Medicine ◽  
2012 ◽  
Vol 7 (2) ◽  
pp. 154-162
Author(s):  
Jolanta Marucha ◽  
Agnieszka Jurecka ◽  
Agnieszka Różdżyńska-Świątkowska ◽  
Anna Tylki-Szymańska
Keyword(s):  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Joint Involvement ◽  
Wrist Flexion ◽  
Enzyme Replacement ◽  
Shoulder Flexion ◽  
Arylsulfatase B ◽  
Musculoskeletal Manifestations ◽  
Mucopolysaccharidosis Vi ◽  
Human Arylsulfatase

AbstractThe aim of this study was to describe the musculoskeletal manifestations of mucopolysaccharidosis VI and to assess the effectiveness of enzyme replacement therapy (ERT) with recombinant human arylsulfatase B on the bone and joint involvement in a patient with a severe phenotype of the disease. Before the initiation of ERT, the patient presented with significant range of motion (ROM) limitations at multiple joints. Flexion contractures were noticeable in all joints. After 48 weeks of ERT, improvement in active and passive shoulder flexion, as well as passive elbow and wrist flexion, was noticed. ROM improvements were reflected in patient’s enhanced self-care.

Sign in / Sign up

Export Citation Format

Share Document